• Imaging agents

Bludigo Generic Name & Formulations

General Description

Indigotindisulfonate sodium 8mg/mL; dark blue soln for IV inj.

Pharmacological Class

Diagnostic aid.

How Supplied

Single-dose ampules (5mL)—5


Generic Availability


Bludigo Indications


As a visualization aid in the cystoscopic assessment of the integrity of the ureters following urological and gynecological open, robotic, or endoscopic surgical procedures.

Bludigo Dosage and Administration


Give 5mL by IV inj over 1min. Within 4–9mins after IV inj, blue color is detectable at the ureteral orifices.


Not established.

Bludigo Contraindications

Not Applicable

Bludigo Boxed Warnings

Not Applicable

Bludigo Warnings/Precautions


Risk of severe or life-threatening cardiovascular reactions within 60mins after inj (eg, cardiac arrest, arrhythmia, asystole, 2nd degree AV block, hypotension, elevated BP, bradycardia, tachycardia); interrupt administration if reactions occur. Hypertension. Heart rate or conduction disorders. Closely monitor BP and cardiac rhythm during and following inj. Monitor for anaphylactic reactions. Have emergency equipment and trained personnel readily available. May transiently interfere with pulse oximetric methods. Potential for artifactual reduction in SpO2 in anesthetized patients. Renal impairment (eGFR <30mL/min): not recommended. Pregnancy. Nursing mothers.

Bludigo Pharmacokinetics

See Literature

Bludigo Interactions


Increased risk for elevated blood pressure, hypotension, bradycardia with concomitant drugs that can cause bradycardia.

Bludigo Adverse Reactions

Adverse Reactions

Constipation, nausea, vomiting, abdominal pain, pyrexia, increased ALT, dysuria; hypersensitivity reactions.

Bludigo Clinical Trials

See Literature

Bludigo Note

Not Applicable

Bludigo Patient Counseling

See Literature